Synthesis and antibacterial activities of optically active ofloxacin. - Wikidata - awgldk - TriplyDB

Synthesis and antibacterial activities of optically active ofloxacin.

Synthesis and antibacterial activities of optically active ofloxacin.

http://www.wikidata.org/entity/Q39850799

about

DNA gyrase, topoisomerase IV, and the 4-quinolones Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide Mechanism of differential activities of ofloxacin enantiomers Crystal Structure-Based Selective Targeting of the Pyridoxal 5′-Phosphate Dependent Enzyme Kynurenine Aminotransferase II for Cognitive Enhancement In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine Screening and its potential application of lipolytic activity from a marine environment: characterization of a novel esterase from Yarrowia lipolytica CL180.Liquid chromatographic resolution of gemifloxacin mesylate on a chiral stationary phase derived from crown ether.Characterization and its potential application of two esterases derived from the arctic sediment metagenome.Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.The evolving role of chemical synthesis in antibacterial drug discovery.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group.In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.In vitro activity of DR-3355, an optically active ofloxacin In vitro activity of S-ofloxacin.Pharmacokinetic study of ofloxacin enantiomers in Pagrosomus major by chiral HPLC.Synergy of levofloxacin (L-ofloxacin) and oxacillin against quinolone-resistant Staphylococcus aureus, measured by the time-kill method.Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzyme.Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model Susceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacin.Investigation of enantioselective ofloxacin-albumin binding and displacement interactions using capillary affinity zone electrophoresis.Post-marketing surveillance of the safety of levofloxacin in Japan.Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases.In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.Nature versus nurture in two highly enantioselective esterases from Bacillus cereus and Thermoanaerobacter tengcongensis.Inhaled antibiotics for gram-negative respiratory infections.Asymmetric organocatalysis at the service of medicinal chemistry Safety and tolerability profile of second-line anti-tuberculosis medications.The stereoselectivity of drug action.Chiral separation of quinolones by liquid chromatography and capillary electrophoresis.The 4-quinolone antibiotics: past, present, and future.Organocatalytic Transfer Hydrogenation and Hydrosilylation Reactions.Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene Absorption of ofloxacin isomers in the rat small intestine.Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells.Inhibition of DNA gyrase by optically active ofloxacin

P2860

Q24643546-324A8B28-EA9B-440F-9199-E69251CD9FF2 Q24671290-D7A7FAEA-9D87-4399-9238-5110F8B3380E Q24675769-73139967-025B-4274-8A49-2094FB3758CD Q27663873-D3AF4BE7-3C4F-4623-8A06-671364CCCDB3 Q28367763-F97BC566-CEEB-4D07-A348-27DC5B6A3476 Q28379074-EF282338-CF62-4C3F-9534-13BB7214CD70 Q28379137-97A263A5-8F57-4459-A9C3-4F57A659E35E Q28379290-54099A93-5968-41D8-924B-C3F0A3928588 Q30828107-DF69A7C1-FED2-4E48-84B3-F6191DB123A2 Q31107852-9413A5B4-F533-4E30-8F18-DAA6EA92C062 Q33371586-A8D20AB4-E75B-4BE4-844A-2F75CDCD7197 Q34333286-3D75FEC4-E2B3-4788-8E00-D39290A31C3B Q34427652-467D5612-44AD-4D18-A4FE-90D26F6FAB6A Q34687048-1794D456-C810-4C29-926F-ABE9F367E82F Q35125533-F6D64190-D587-410A-8BF1-E549A6362472 Q35340351-716EA0A2-523C-4687-9ECE-D60951BAF56E Q35543768-42164C02-5239-4EB1-9808-CEE5962FF9B5 Q35563775-CF3A46C9-6BB3-44BB-B3EF-7B96B57124CE Q35566524-E5537279-EA57-4460-AA4A-923C88995CA3 Q35693178-430992D7-7C8C-4D64-B4C1-5BC0E28FB925 Q35809150-0AE9DB4B-04DD-434F-87B8-9FC7D9624400 Q35810950-C9A4A01F-FC76-4CF9-A4F4-8B0E7787A0CD Q35822889-2E6A89FD-1EC5-4453-B082-C4AEEBA4594C Q36517614-A569770E-2CFA-48DC-AFA4-E457942CF81E Q36709383-6EA7F833-4D69-433E-ADC9-0A2F28E13DEE Q36720778-A3A91D60-03F3-4004-9D98-B88C0DF346FC Q36752886-A2626F7D-8F14-4F95-BD6A-5E3807BCB7A3 Q36753046-2DBC8CAB-B912-4BEA-B7D4-40CADC21F93B Q37274933-CD96AAA9-349F-457F-B846-41282198396A Q37937558-460DEF60-3318-4C92-978E-38A30EACBBC0 Q38223762-E5163037-5DA2-44B4-878E-4962B8AC890F Q38353565-D0E71C7C-2BEA-4A90-8C70-D1CE1132580C Q38766846-65AE96EF-3357-4726-9166-D6611C67D743 Q39311454-DE1E1549-14F9-4EC9-B4E5-2BF3056534E1 Q39314610-15A891BB-B62B-4D08-B464-CD739C065084 Q39442487-C5E7B53C-7521-42A1-9502-A85F309EAC3F Q39781656-FB9C5652-2CB6-4991-AA75-44B8891D792F Q39785111-43B16108-5179-4713-B6B5-FF5BA95840DD Q39815370-46B9AEB3-EFE7-4940-A417-B4877CA988A5 Q39827737-6D697EA2-5A6B-4515-B6EE-F668863EE21C

P2860

Synthesis and antibacterial activities of optically active ofloxacin.

http://www.wikidata.org/entity/Q39850799

description

1986 nî lūn-bûn

@nan

1986年の論文

@ja

1986年学术文章

@wuu

1986年学术文章

@zh-cn

1986年学术文章

@zh-hans

1986年学术文章

@zh-my

1986年学术文章

@zh-sg

1986年學術文章

@yue

1986年學術文章

@zh

1986年學術文章

@zh-hant

name

Synthesis and antibacterial activities of optically active ofloxacin.

@en

Synthesis and antibacterial activities of optically active ofloxacin.

@nl

type

label

Synthesis and antibacterial activities of optically active ofloxacin.

@en

Synthesis and antibacterial activities of optically active ofloxacin.

@nl

prefLabel

Synthesis and antibacterial activities of optically active ofloxacin.

@en

Synthesis and antibacterial activities of optically active ofloxacin.

@nl

P1433

Q39850799-92CEE879-D62D-4E93-A2AB-F3989F140ED9

P1476

Q39850799-A42EA827-AF43-4702-A82C-752FE859F193

P2093

Q39850799-262C70FC-9496-48F0-91BB-92FCFB44D81A

Q39850799-33FB4FA1-F5E6-4B45-A087-206DBB166F63

Q39850799-92E54F7E-E2BE-4434-89F3-A258D0973DBC

Q39850799-D64E4226-4A58-448E-974D-56C1BB36D0C0

Q39850799-D8D9F588-E01A-4DB1-A3BA-ABC3F8A758EE

Q39850799-F542E03B-DF65-4FDC-8FD4-004FF45476AA

P2860

Q39850799-24EADE28-0505-4B8B-A564-ED4F83CE9A4F

Q39850799-78C17343-1624-4349-BBB5-CEF9579DC5F9

Q39850799-82E6CFA8-6A22-4779-AD21-5D6FA98D1CFA

Q39850799-946DA000-5C6D-4B48-885E-8D00526A7BEC

P304

Q39850799-6B0601C0-8E2B-4906-8D58-E244B2C04D0B

P31

Q39850799-E56C72AC-CF6A-43A4-87C1-19029B2A8C6E

P356

Q39850799-47CF30E2-34C6-46EF-B8F5-54F2ADA91679

P407

Q39850799-24AFF2A5-4E87-4AD2-A151-97F97C757428

P433

Q39850799-A33677E9-DF99-40EA-8123-8772A357DD81

P478

Q39850799-2ACE2D6B-75B7-4ABE-AB89-49D264A8D4D5

P577

Q39850799-CC9EA32A-7952-4D97-9D16-6EBBB34057F1

P698

Q39850799-7CB5EF58-5BB9-402F-8F8D-D0AD1B300B5E

P932

Q39850799-0243BD72-9344-4B4F-BDBA-7150749EF39F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Synthesis and antibacterial activities of optically active ofloxacin.

@en

P2093

I Hayakawa

http://www.w3.org/2001/XMLSchema#string

K Sakano

http://www.w3.org/2001/XMLSchema#string

M Furukawa

http://www.w3.org/2001/XMLSchema#string

M Imamura

http://www.w3.org/2001/XMLSchema#string

S Atarashi

http://www.w3.org/2001/XMLSchema#string

S Yokohama

http://www.w3.org/2001/XMLSchema#string

P2860

Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids

Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.

Development of antibacterial agents of the nalidixic acid type.

1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

P304

163-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.29.1.163

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

1986-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3460520

http://www.w3.org/2001/XMLSchema#string

P932

180386

http://www.w3.org/2001/XMLSchema#string